Carret Asset Management’s GSK GSK Stock Holding History

Carret Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,367	Closed	-$252K	–	261
2015 Q1	$252K	Hold	4,367	–	–	0.05%	219
2014 Q4	$233K	Hold	4,367	–	–	0.04%	228
2014 Q3	$251K	Sell	4,367 -1,200	-22%	-$73.6K	0.05%	223
2014 Q2	$372K	Buy	5,567 +896	+19%	+$60.6K	0.07%	195
2014 Q1	$312K	Hold	4,671	–	–	0.06%	203
2013 Q4	$312K	Sell	4,671 -280	-6%	-$18.2K	0.06%	204
2013 Q3	$311K	Sell	4,951 -80	-2%	-$5.15K	0.07%	196
2013 Q2	$314K	Buy	+5,031	New	+$319K	0.07%	232

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carret Asset Management's GSK Position: Q2 2015 in Review

Carret Asset Management sold out of GSK (GSK) in Q2 2015, closing a stake of 4,367 shares — an estimated $252K sold.

Carret Asset Management first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $372K in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Carret Asset Management reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
Carret Asset Management sold 4,367 GSK shares in Q2 2015, an estimated $252K.
Carret Asset Management first reported a position in GSK in Q2 2013 and held it in 8 quarters.
Carret Asset Management's GSK position peaked at $372K in Q2 2014.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Carret Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.